Aptevo Therapeutics Inc. Skyrocketed
Wed, Nov 04, 2020 at 05:30 PM
Aptevo Therapeutics Inc. (APVO:NASDAQ) rocketted at $16.98, a gain of 51.2%. On Tue 03 Nov 20, APVO:NASDAQ hit a New 2-Week High of $11.23. The stock got featured on our News Catalysts scanner on Tue 03 Nov 20 at 01:12 PM in the 'BIOTECH' category. From Tue 20 Oct 20, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Thu 25 Jun 20 at $11.73 with a volume of 31M+.
About Aptevo Therapeutics Inc. (APVO:NASDAQ)
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.
Top 10 Gainers:
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 51.2%
- Biogen Inc. (BIIB:NASDAQ), 43.97%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 25.57%
- ATHA (ATHA:NASDAQ), 24.13%
- ATHA (ATHA:NYSE), 24.13%
- Supernus Pharmaceuticals, Inc. (SUPN:NASDAQ), 23.8%
- XPEV (XPEV:NYSE), 23.32%
- Prothena Corporation plc (PRTA:NASDAQ), 22.71%
- THRY (THRY:NASDAQ), 18.87%
- Kandi Technologies Group, Inc. (KNDI:NASDAQ), 18.64%